Our Pipeline
ONO is investigating additional molecules across our four focus areas in clinical trials around the world.
92
Clinical trial sites in the U.S.
7
Clinical trials ongoing in the U.S.
Pipeline updated as of July 22, 2024.
Combination with nivolumab
Mechanism
Disease Area
Country
Licensor
Development Phase
Neurology
Phase 1
Phase 2
Phase 3
Filing
Approval
P1
P2
P3
F
A
ONO-1110
Endocannabinoid regulation
ONO-2020
Epigenetic regulation
ONO-2808
S1P5 receptor agonist
ONO-2910
Enhancement of Schwann cell differentiation
INNOVATION AROUND THE WORLD
Our Global Pipeline
ONO is investigating additional therapeutics across our four focus areas globally.
Get in touch to learn more.
Explore what it’s like to work at ONO PHARMA USA.